THBD and endothelial dysfunction: In a cross-sectional study of 55 T2DM patients, soluble thrombomodulin, another marker of endothelial dysfunction and potent activator of TAFI, was reported to be increased by 45% in patients with an HbA1c of 9.1%, when compared to control subjects [60].